[FATE] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
28-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -58.45%
YoY- -29.20%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 14,981 18,549 18,414 17,067 14,225 13,412 11,142 21.79%
PBT -83,563 -76,105 -65,690 -68,621 -43,308 -55,133 -45,089 50.82%
Tax -2,828 -757 -8,777 -2,206 -11,315 8,354 -1,121 85.21%
NP -80,735 -76,105 -56,913 -68,621 -43,308 -55,133 -45,089 47.40%
Tax Rate - - - - - - - -
Total Cost 95,716 94,654 75,327 85,688 57,533 68,545 56,231 42.51%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -538.92 -410.29 -309.07 -402.07 -304.45 -411.07 -404.68 21.02%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.83 -0.79 -0.59 -0.72 -0.45 -0.58 -0.48 44.01%
EPS Diluted -0.83 -0.79 -0.59 -0.72 -0.45 -0.58 -0.48 44.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.